Myriad Genetics, Hereditary Cancer
Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce that it has ...
Group meeting and tour of company headquarters with CEO Diaz, COO Raha and CFO Leffler in Salt Lake City, Utah on February 10 hosted by ...
Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...
The decentralized prediction market is one of the main apps featured on Abstract’s portal for the Abstract Global Wallet.
Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") announces that Ian Archbold has assumed a ...
Pokémon Trading Card Game Pocket has a strange black market where players are buying and selling the digital cards online via ...
Myriad Genetics (MYGN) and Lumea have signed an agreement to integrate Myriad’s advanced molecular diagnostic tests – Prolaris Prostate Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results